|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | |||||||||||||||||
| Accounts receivable, net | |||||||||||||||||
| Inventory | |||||||||||||||||
| Prepaid/in-transit inventory | |||||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||||
| Total current assets | |||||||||||||||||
| Property and equipment | |||||||||||||||||
| Accumulated depreciation | |||||||||||||||||
| Property and equipment, net | |||||||||||||||||
| Other Assets | |||||||||||||||||
| Operating leases – right-of-use asset | |||||||||||||||||
| Deposits | |||||||||||||||||
| Total other assets | |||||||||||||||||
| Total assets | |||||||||||||||||
| Accounts payable | |||||||||||||||||
| Customer deposits | |||||||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||||||
| Convertible note | |||||||||||||||||
| Derivative liability - warrants | |||||||||||||||||
| Current portion of operating lease liability | |||||||||||||||||
| Current portion of stockholder promissory notes | |||||||||||||||||
| Current portion of long-term debt | |||||||||||||||||
| Suspended liability | |||||||||||||||||
| Total current liabilities | |||||||||||||||||
| Long-term debt, net of current portion and discount | |||||||||||||||||
| Operating lease liability, net of current portion | |||||||||||||||||
| Stockholder promissory notes, net of current portion | |||||||||||||||||
| Total liabilities | |||||||||||||||||
| Common stock, par value $0.001; 1,666,666 shares authorized; 953,192 and 815,145 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | |||||||||||||||||
| Additional paid-in capital | |||||||||||||||||
| Accumulated deficit | |||||||||||||||||
| Total stockholders’ equity | |||||||||||||||||
| Total liabilities and stockholders’ equity | |||||||||||||||||
Loading...
